CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion 03/15/2021 Company news Read press release
10/14/2021 | Company news BICO strengthens IP portfolio with two additional patents for 3D bioprinting
09/22/2021 | Industry News BICO Launches 3D Bioprinting Contract Research Offering From CELLINK, MatTek and Visikol
04/14/2021 | Biotech CELLINK receives the prestigious gold award for the BIO X6 and wins two design excellence awards for the C.WASH and UP.SIGHT at the iF Design Awards 2021
04/14/2021 | Industry News CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments
03/23/2021 | Company news BIO X6 wins prestigious Red Dot Design Award for outstanding design quality
03/15/2021 | 3d bioprinting CELLINK launches the BIO MDX Series, a scaled-up revolution in biomedical manufacturing